Concord Biotech Limited Incorporated in 1984, Company is an India-based R&D-driven biopharma company. The company is ranked among the leading global developers and manufacturers of select fermentation-based APIs across immunosuppressants and oncology in terms of market share, based on volume in 2022. Concord Biotech is a niche biopharma company manufacturing APIs (active pharmaceutical ingredients) and formulations for select therapeutic areas. Operating in the B2B segment, it develops (a) APIs through fermentation as well as semi-synthetic processes, across therapeutic areas of immunosuppressants, oncology, and anti-infectives. (b) formulations, which are used in…
Read MoreConcord Biotech Limited IPO
